Compassionate Use of Tocilizumab in Severe SARS-CoV2 Pneumonia. When late administration is too late.

Miguel Gorgolas; Alfonso Cabello; Laura Prieto Perez; Felipe Villar Alvarez; Beatriz Alvarez Alvarez; Maria Jesus Rodriguez Nieto; Irene Carrillo Acosta; Itziar Fernandez Ormaechea; Aws Al-Hayani; Pilar Carballosa; Silvia Calpena Martinez; Farah Ezzine de Blas; Marina Castellanos Gonzalez; Alba Naya Prieto; Marta Lopez de las Heras; Marcel Jose Rodriguez Guzman; Ana Cordero Guijarro; Antonio Broncano Lavado; Alicia Macias Valcayo; Marta Martin Garcia; Javier Becares Martinez; Ricardo Fernandez Roblas; Miguel A Piris Pinilla; Jose Fortes Alen; Olga Sanchez Pernaute; Fredeswinda Romero Bueno; Sarah Heili Frades; German Peces Barba Romero

doi:10.1101/2020.06.13.20130088

Compassionate Use of Tocilizumab in Severe SARS-CoV2 Pneumonia. When late administration is too late.

View ORCID ProfileMiguel Gorgolas, Alfonso Cabello, Laura Prieto Perez, Felipe Villar Alvarez, Beatriz Alvarez Alvarez, Maria Jesus Rodriguez Nieto, Irene Carrillo Acosta, Itziar Fernandez Ormaechea, Aws Al-Hayani, Pilar Carballosa, Silvia Calpena Martinez, Farah Ezzine de Blas, Marina Castellanos Gonzalez, Alba Naya Prieto, Marta Lopez de las Heras, Marcel Jose Rodriguez Guzman, Ana Cordero Guijarro, Antonio Broncano Lavado, Alicia Macias Valcayo, Marta Martin Garcia, Javier Becares Martinez, Ricardo Fernandez Roblas, Miguel A Piris Pinilla, Jose Fortes Alen, Olga Sanchez Pernaute, Fredeswinda Romero Bueno, Sarah Heili Frades, German Peces Barba Romero

doi: https://doi.org/10.1101/2020.06.13.20130088

Miguel Gorgolas